Literature DB >> 26590892

Colpocleisis surgery in women over 80 years old with severe triple compartment pelvic organ prolapse.

Haim Krissi1, Amir Aviram2, Edward Ram3, Ram Eitan2, Arnon Wiznitzer2, Yoav Peled2.   

Abstract

OBJECTIVE: To compare outcomes of Le Fort colpocleisis surgery, between women over 80 years old and younger women. STUDY
DESIGN: We searched the medical files for all consecutive women who underwent Le Fort colpocleisis as a primary or recurrent surgery for severe pelvic organ prolapse at our university-affiliated tertiary center between February 2007 and July 2013. Exclusion criteria for performance of the procedure were post-menopausal bleeding, pelvic malignancy, pelvic irradiation, and the desire to preserve coital function. The objective and subjective recurrence of prolapse, intraoperative and postoperative complications, and patient satisfaction were measured.
RESULTS: Forty-seven women underwent Le Fort colpocleisis. Of them, 23 were above 80 years, mean age 84.0±3.3, oldest: 91; and 24 were 80 years old and younger, mean age 70.8±6.1, youngest: 61. There were no intraoperative complications. Postoperative complications were recorded for 2 women with lower urinary tract infection and one woman had longer hospitalization time for warfarin treatment adjustment (9 days). Objective cure rates were 82.7% (19/23) and 83.3% (20/24), p=0.32, for women over 80, and women aged 80 and younger, respectively. The subjective cure rate was 86.7% (20/23) and 91.6% (22/24), respectively, p=0.28.
CONCLUSIONS: Objective and subjective cure rates of Le Fort colpocleisis in women over age 80 years were similar to those for younger women. The complications were mild and few, and unrelated to age. This procedure may be offered for women over 80 years old with severe symptomatic pelvic organ prolapse and medical comorbidities.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Colpocleisis; Elderly; Outcome; Pelvic organ prolapse

Mesh:

Year:  2015        PMID: 26590892     DOI: 10.1016/j.ejogrb.2015.10.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.831


  7 in total

1.  Risk factors predicting the loss of functional independence after obliterative procedures for pelvic organ prolapse.

Authors:  Logan Blankenship; Meadow M Good; Carmen Smotherman; Shiva Gautam; Ruchira Singh
Journal:  Int Urogynecol J       Date:  2020-07-10       Impact factor: 2.894

2.  Frailty and the Role of Obliterative versus Reconstructive Surgery for Pelvic Organ Prolapse: A National Study.

Authors:  Anne M Suskind; Chengshi Jin; Louise C Walter; Emily Finlayson
Journal:  J Urol       Date:  2016-12-06       Impact factor: 7.450

Review 3.  How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature.

Authors:  Laetitia Felder; Viola Heinzelmann-Schwarz; Tilemachos Kavvadias
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

Review 4.  Colpocleisis as an obliterative surgery for pelvic organ prolapse: is it still a viable option in the twenty-first century? Narrative review.

Authors:  Magdalena Emilia Grzybowska; Konrad Futyma; Aida Kusiak; Dariusz Grzegorz Wydra
Journal:  Int Urogynecol J       Date:  2021-08-18       Impact factor: 1.932

Review 5.  Management of pelvic organ prolapse in the elderly - is there a role for robotic-assisted sacrocolpopexy?

Authors:  Hadley Narins; Teresa L Danforth
Journal:  Robot Surg       Date:  2016-10-17

6.  Management of pelvic organ prolapse of ruptured and extruded bladder from a rare complication of vaginal hysterectomy: a case presentation.

Authors:  Piao-Piao Ye; Xiao-Jian Yan; Yasmeen Bano; Hong-Qin Zhao; Feng-Feng Xie; Fang-Yi Zhang; Yu-Feng Wang; Hui Xie; Hai-Hong Jiang
Journal:  BMC Surg       Date:  2021-01-19       Impact factor: 2.102

7.  Surgical and quality of life outcomes after pelvic organ prolapse surgery in older postmenopausal women.

Authors:  Mohamed M Farghali; Abeer Abdelzaher; Ibrahim A Abdelazim
Journal:  Prz Menopauzalny       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.